Showing results (11-20 of 60) with videos related to
Sort By:
Pageof 6
Journal of Visualized Experiments : Jove|October 21, 2015
Automated Cell Enrichment of Cytomegalovirus-specific T cells for Clinical Applications using the Cytokine-capture SystemPappanaicken Kumaresan, Mathew Figliola, Judy S Moyes, et al.Cytotherapy|December 17, 2011
Production of good manufacturing practice-grade cytotoxic T lymphocytes specific for Epstein-Barr virus, cytomegalovirus and adenovirus to prevent or treat viral infections post-allogeneic hematopoietic stem cell transplantUluhan Sili, Ann M Leen, Juan F Vera, et al.Journal of Immunology (Baltimore, Md. : 1950)|September 9, 2005
Characterization of latent membrane protein 2 specificity in CTL lines from patients with EBV-positive nasopharyngeal carcinoma and lymphomaKarin C Straathof, Ann M Leen, Elizabeth L Buza, et al.Clinical Cancer Research : an Official Journal of the American Association for Cancer Research|July 5, 2012
A new approach to simultaneously quantify both TCR α- and β-chain diversity after adoptive immunotherapyMinying Zhang, Sourindra Maiti, Chantale Bernatchez, et al.Cancer Gene Therapy|December 20, 2003
A strategy for treatment of Epstein-Barr virus-positive Hodgkin's disease by targeting interleukin 12 to the tumor environment using tumor antigen-specific T cellsHans-Joachim Wagner, Catherine M Bollard, Stéphane Vigouroux, et al.Blood|April 20, 2002
Adapting a transforming growth factor beta-related tumor protection strategy to enhance antitumor immunityCatherine M Bollard, Claudia Rössig, M Julia Calonge, et al.Journal of Visualized Experiments : Jove|February 15, 2013
Clinical application of Sleeping Beauty and artificial antigen presenting cells to genetically modify T cells from peripheral and umbilical cord bloodM Helen Huls, Matthew J Figliola, Margaret J Dawson, et al.Blood|January 31, 2004
Prompt versus preemptive intervention for EBV lymphoproliferative diseaseHans-Joachim Wagner, Yee Chung Cheng, M Helen Huls, et al.Plos One|August 23, 2016
Redirecting Specificity of T cells Using the Sleeping Beauty System to Express Chimeric Antigen Receptors by Mix-and-Matching of VL and VH Domains Targeting CD123+ TumorsRadhika Thokala, Simon Olivares, Tiejuan Mi, et al.Molecular Therapy : the Journal of the American Society of Gene Therapy|January 9, 2013
Bispecific T-cells expressing polyclonal repertoire of endogenous γδ T-cell receptors and introduced CD19-specific chimeric antigen receptorDrew C Deniger, Kirsten Switzer, Tiejuan Mi, et al.Pageof 6